Evidence map›Paper›PMID 26762359›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2016

Treatment variation in stent choice in patients with stable or unstable coronary artery disease.

L T Burgers, E A McClellan, I E Hoefer, G Pasterkamp, J W Jukema, S Horsman, N H J Pijls, J Waltenberger, M A Hillaert, A C Stubbs and 2 more

Abstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Evaluation of bifurcation stenting techniques at Catharina Hospital, Eindhoven in 2013.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2017
    Article
  3. Unwarranted variation of coronary stent choice in The Netherlands.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2016
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

L T BurgersInstitute of Health Policy & Management, and Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands. ltburgers@gmail.com.
E A McClellanDepartment of Mathematical and Computer Sciences, Metropolitan State University of Denver, Colorado, USA.
I E HoeferLaboratory of Experimental Cardiology, UMC Utrecht, Utrecht, The Netherlands.
G PasterkampLaboratory of Experimental Cardiology, UMC Utrecht, Utrecht, The Netherlands.
J W JukemaDepartment of Cardiology, Leiden UMC, Leiden, The Netherlands.
S HorsmanDepartment of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
N H J PijlsDepartment of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
J WaltenbergerDepartment of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
M A HillaertDepartment of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
A C StubbsDepartment of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
J L SeverensInstitute of Health Policy & Management, and Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
W K RedekopInstitute of Health Policy & Management, and Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimVariations in treatment are the result of differences in demographic and clinical factors (e.g. anatomy), but physician and hospital factors may also contribute to treatment variation. The choice of treatment is considered important since it could lead to differences in long-term outcomes. This study explores the associations with stent choice: i.e. drug-eluting stent (DES) versus bare-metal stents (BMS) for Dutch patients diagnosed with stable or unstable coronary artery disease (CAD). METHODS &

resultsAssociations with treatment decisions were based on a prospective cohort of 692 patients with stable or unstable CAD. Of those patients, 442 patients were treated with BMS or DES. Multiple logistic regression analyses were performed to identify variables associated with stent choice. Bivariate analyses showed that NYHA class, number of diseased vessels, previous percutaneous coronary intervention, smoking, diabetes, and the treating hospital were associated with stent type. After correcting for other associations the treating hospital remained significantly associated with stent type in the stable CAD population.

conclusionsThis study showed that several factors were associated with stent choice. While patients generally appear to receive the most optimal stent given their clinical characteristics, stent choice seems partially determined by the treating hospital, which may lead to differences in long-term outcomes.

Indexed as

Bare-metal stentCoronary artery diseaseDrug-eluting stentPercutaneous coronary interventionTreatment variation

Identifiers

PMID26762359
PMCPMC4722012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.